Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Zhong E, Swistel A, Viswanathan K, Hoda SA. Leiomyoma of the Nipple: A common neoplasm in an uncommon location. Breast J. 2020;26(3):529-530.

Rendeiro AF, Ravichandran H, Bram Y, Salvatore S, Borczuk A, Elemento O, et al. The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection. medRxiv. 2020.

Sanchez AM, Garg A, Shuman S, Schwer B. Genetic interactions and transcriptomics implicate fission yeast CTD prolyl isomerase Pin1 as an agent of RNA 3' processing and transcription termination that functions via its effects on CTD phosphatase Ssu72. Nucleic Acids Res. 2020;48(9):4811-4826.

Zhong E, Solomon JP, Cheng E, Baum J, Song W, Hoda SA. Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity. Am J Surg Pathol. 2020;44(8):1092-1103.

Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020;127(12):1548-1556.

Solomon JP, Arcila ME. Molecular Diagnostics of Non-Hodgkin Lymphoma. Cancer J. 2020;26(3):186-194.

Strother RM, Gopal S, Wirth M, Chadburn A, Noy A, Cesarman E, et al. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO Glob Oncol. 2020;6:1034-1040.

Chaekal O-, Scaradavou A, Frenet EM, Albano MS, Cushing M, Desai P, et al. Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood Adv. 2020;4(20):5146-5156.

Galassi TV, Antman-Passig M, Yaari Z, Jessurun J, Schwartz RE, Heller DA. Long-term in vivo biocompatibility of single-walled carbon nanotubes. PLoS One. 2020;15(5):e0226791.

Stopsack KH, Gerke T, Zareba P, Pettersson A, Chowdhury D, Ebot EM, et al. Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer. Carcinogenesis. 2020;41(7):904-908.